Radialis Garners FDA 510(k) Clearance for Portable PET Device
Offering images of high spatial resolution and a small system footprint, the new positron emission tomography (PET) modality from Radialis may facilitate enhanced imaging of emerging radiotracer agents and key biomarkers in targeted organs.
The Food and Drug Administration (FDA) has granted 510(k) clearance to the Radialis PET Imager, an emerging portable complement to traditional positron emission tomography/computed tomography (PET/CT) systems.
Specially designed for organ-targeted, close-range imaging, the Radialis PET Imager reportedly has increased sensitivity to radiotracer imaging agents, according to Radialis, the manufacturer of the device.
The company said the device combines a partial-ring plantar PET camera and lutetium-containing gamma ray detectors. The Radialis PET Imager can visualize any injected positron-emitting radiotracer agent and provide images of high spatial resolution, noted Radialis.
Radialis said the device also has two plantar detectors that can be adjusted as necessary to allow a variety of scans and adaptability to patients who are lying down, standing, or sitting. The portability of the 4.5 feet high device also facilitates smoother incorporation into existing nuclear medicine facilities, according to Radialis.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 5th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 5th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
August 5th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
